HCI Group reports Q1 2026 results on May 8 with its stock trading well below analyst targets — a gap that frames the core debate for tomorrow's print.
The analyst setup tells the most interesting story here. The two analysts covering HCI both carry buy-equivalent ratings, with a consensus price target of $245 against a current close of $153.91 — implying roughly 59% upside. The most recent analyst actions, from November 2025, were constructive: Citizens raised its target to $255 and Truist lifted to $235, both after the prior quarter. That Oppenheimer downgraded to Perform at the same time tempers the picture slightly. The stock is down 22% year-to-date, meaning even the bulls are sitting on a significant drawdown. What the earnings print needs to do is close that confidence gap.
The bull case rests on Florida legislative reform. Reduced litigation and fraud have improved loss ratios materially, and the company's track record of disciplined underwriting in the state's residential market gives it a structural edge when conditions are cooperative. Bears point to the same geography as the risk — Florida hurricane exposure, regulatory unpredictability, and the sensitivity of the homeowners' book to any reversal in the reform-era tailwinds. The spin-off of Exzeo adds a technology angle, but it also removes a growth asset from the consolidated story. Estimated revenue near $994 million and net income around $218 million imply an EPS of roughly $16.98, which at $153.91 per share puts the trailing multiple around 9x — cheap if the earnings quality holds.
Positioning heading into the print is notably relaxed. Short interest is just 2.2% of the free float, with borrow costs running at only 0.29% — effectively free. Availability in the lending market is deep, meaning there is no shortage of shares for shorts even if sentiment sours. The ORTEX short score of 31.4 is well below any level that would signal aggressive bearish conviction. Options lean slightly more cautious — the put/call ratio has drifted up to 0.34 from a 20-day average of 0.32, though the z-score of 0.75 is far from alarming. The last two confirmed earnings reactions show a wide range: a 2% gain on the day in February 2026 following one release, and an 8.7% surge with an 11.3% five-day follow-through from the same month's adjacent event.
The print will test whether a nearly $100 gap between price and consensus is a valuation opportunity or a warning — and whether Florida's improving claims environment has actually flowed through to the bottom line in a way that justifies rebuilding that confidence.
See the live data behind this article on ORTEX.
Open HCI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
